[Morphologic study of iliac crest spongiosa in patients with osteoporosis treated with combination therapy of pulsatile administration of parathyroid hormone (1-38 hPTH) and sequential addition of calcitonin nasal spray]
- PMID: 2319988
[Morphologic study of iliac crest spongiosa in patients with osteoporosis treated with combination therapy of pulsatile administration of parathyroid hormone (1-38 hPTH) and sequential addition of calcitonin nasal spray]
Abstract
Seven patients with clinically and histologically proven osteoporosis were treated with intermittent doses of parathyroid hormone fragment (hPTH 1-38) in combination with sequential administration of calcitonin by nasal spray. Iliac crest bone biopsies were taken before and after 14 month of treatment. Under treatment we found a moderate increase in the number of osteoclasts without signs of an increased depth of resorption lacunae.No loss of complete trabeculae due to osteoclastic perforation could be demonstrated. In contrast, we found a drastic increase in the layers of osteoblasts covering osteoid tissue by about 100%. Mineralisation defects or endosteal fibrosis were not present in any case. Mean bone volume (BV/TV) increased under treatment from 12.1% to 16.8% (relative increase of 38%) and was due to a thickening of the individual trabeculae in all seven cases. Considering the small number of patients analysed, the described treatment regimen seems to be efficient on a histological point of view.
Similar articles
-
[Early therapy of osteoporosis with (1-38) parathyroid hormone and calcitonin nasal spray].Med Klin (Munich). 1989 Oct 15;84(10):488-98. Med Klin (Munich). 1989. PMID: 2685534 Review. German. No abstract available.
-
[Morphologic study of iliac crest spongiosa in patients with osteoporosis treated according to the ADFR (activation, depression of resorption, formation, repeat the cycle) with parathyroid hormone and diphosphonates (Hannover PTH I study)].Z Orthop Ihre Grenzgeb. 1990 Jan-Feb;128(1):1-5. doi: 10.1055/s-2008-1039852. Z Orthop Ihre Grenzgeb. 1990. PMID: 2138378 German.
-
[Therapy of osteoporosis using the ADFR schedule (especially with parathyroid hormone and etidronate)].Internist (Berl). 1991 Feb;32(2):76-9. Internist (Berl). 1991. PMID: 1903362 Review. German. No abstract available.
-
Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment.J Bone Miner Metab. 2004;22(6):569-76. doi: 10.1007/s00774-004-0525-z. J Bone Miner Metab. 2004. PMID: 15490267 Clinical Trial.
-
An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.J Clin Invest. 1993 Mar;91(3):1138-48. doi: 10.1172/JCI116273. J Clin Invest. 1993. PMID: 8450043 Free PMC article. Clinical Trial.
Cited by
-
hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses.Osteoporos Int. 1991 Jun;1(3):162-70. doi: 10.1007/BF01625448. Osteoporos Int. 1991. PMID: 1790404
-
Human parathyroid peptide treatment of vertebral osteoporosis.Osteoporos Int. 1993;3 Suppl 1:199-203. doi: 10.1007/BF01621906. Osteoporos Int. 1993. PMID: 8461559
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical